“…Considering that, the standard electrode potential of Zn (−0.76 V SHE ) is between that of Mg (−2.36 V SHE ) and Fe (−0.44 V SHE ), and the mechanical strength of Zn-based metals is superior to that of Mg-based metals . Thus, Zn is considered as a more appropriate implant for cardiovascular stent applications than Mg and Fe in the aspects of preferable corrosion behavior, superior mechanical strength, and acceptable biocompatibility in blood contacting engineering. − The corrosion rate and mechanical strength of Zn are very close to the expected value for biodegradable stents; however, the excessive Zn ion release and fatigue fracture failure during degradation remain huge challenges in clinical practice. − As compared to Zn-based alloys, the in vitro degradation rate of pure Zn decreased to 0.033 mm year –1 as evaluated by the immersion test in Hank’s solution, which is nearly close to the ideal value for biodegradable metals in vascular applications (0.02 mm year –1 ). , Moreover, the median lethal dose values of Zn 2+ have been reported, that is, 50 μM for human dermal fibroblasts (hDF), 70 μM for human aortic smooth muscle cells (AoSMC), and 265 μM for human endothelial cells (HAEC) . Rapid released Zn 2+ can hinder both cell adhesion and mobility, and even quickly cause cell death. , In addition, the stents are subjected to nonuniform corrosion and stress concentration in the complex in vivo environment, eventually resulting in the loss of mechanical support.…”